James N Arnold

7PUBLICATIONS
45CO-AUTHORS
Innate immunityMolecular targetsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2025
An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancer.

Meriem Bahri, Taha Al-Adhami, Emre Demirel

|Aug 26, 2024
PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.

Sarah Spear, Olivia Le Saux, Hasan B Mirza

|May 18, 2023
Perivascular tumor-associated macrophages and their role in cancer progression.

Meriem Bahri, Joanne E Anstee, James W Opzoomer

|Mar 13, 2023
Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue.

Diana Corogeanu, Kam Zaki, Andrew J Beavil

|Nov 03, 2021
Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression.

James W Opzoomer, Joanne E Anstee, Isaac Dean

Pageof 2